الفهرس 
Caesarean SectionOnly 14 pages are availabe for public view
 |  | from | 122 |  |  |
| | | from | 122 | | |
Abstract
Objective: The objective is to determine the role of Prostaglandin E1 on the reduction of the neonatal respiratory morbidity specially (TTN).
Study Design: Parallel, randomized placebo controlled trial, comparing the use of Misoprostol (Prostaglandin E1) use in the form of Misoprostol E1 vaginal tablets with non medicated similar vaginal tablet (placebo) to decrease the neonatal respiratory distress specially (TTN).
Results: study included 300 cases with gestational age range between 38 weeks to less than 39 weeks the included cases were classified into 2 groups: study group included 150 case were given PG E1 control group included 150 case were given placebo.
We found one positive cases for TTN in study group, and 3 positive case for TTN in control group results we got were insignificant. So we suggest taking more large sample in future studies